Ruby QC Investment Holdings Pte sold its entire holding of 72.78 lakh shares (or 4.62 per cent of paid-up equity) in Akums Drugs & Pharmaceuticals for ₹311.5 crore, to ICICI Prudential Mutual Fund. According to bulk deal data with NSE, the shares were sold at an average price of ₹428. ICICI Prudential acquired the entire stake. The stock on Monday closed 3.8 per cent higher at ₹443.70 on the BSE. Ruby QC Investment is associated with Quadria Capital.
Akums Drugs hit the capital market last year in August 2024 at a price band of ₹646-679. After hitting a high of ₹1,066.65 immediately after the listing, the stock has been on a secular downtrend.
Published on December 22, 2025
